510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K940682Substantially Equivalent

Axsym(tm) Quinidine

Abbott Medical, Abbott Park IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K940682 is the FDA 510(k) clearance record for AXSYM(TM) QUINIDINE, a class II device, cleared for Abbott Laboratories on under FDA product code LGI (Fluorescence Polarization Immunoassay, Carbamazepine). FDA records list 1,478 510(k) clearances for Abbott Medical, from to . As of , FDA records show 4 recalls naming K940682.

Clearance record

Decision date
Received
(131 days to decision)
Product code
LGI Fluorescence Polarization Immunoassay, Carbamazepine
Regulation
21 CFR 862.3645
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Abbott Laboratories Dept: 09v8 Bldg: Ap5-2, Abbott Park IL
510(k) summary
Summary
Third party review
No

Clearances, product code LGI

Trailing 12 months

FDA records hold no clearances under product code LGI in the trailing twelve months.

FDA records show no clearances under product code LGI in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LGI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260